A 72-year-old male client is receiving a continuous IV heparin infusion for a left lower-extremity deep vein thrombosis (DVT). The 0600 aPTT is 110 seconds (therapeutic target 60–80 seconds). On assessment the nurse notes pink-tinged urine, gum oozing while brushing teeth, and a new 4 cm bruise on the forearm. Vital signs: BP 138/84, HR 92, RR 18, T 36.7°C, SpO2 97%. Which is the priority nursing action?

The aPTT of 110 seconds is markedly above the therapeutic target (60–80 seconds), and clinical bleeding is already evident (pink-tinged urine = hematuria, gum oozing, new bruise). The priority is to STOP the infusion immediately, notify the provider, and implement bleeding precautions; the provider may order protamine sulfate (the antidote for heparin) and serial labs. Option 1 holds an unrelated LMWH dose but continues the active heparin, leaving the bleeding source unaddressed; waiting for rounds is unsafe. Option 2 — vitamin K is the antidote for warfarin, NOT heparin; the antidote for heparin is protamine sulfate. Option 3 — a 25% rate reduction without provider notification ignores the active bleeding and the magnitude of aPTT elevation; recheck in 6 hours is a delay that violates priority safety.

In-depth explanation

<span class="merci-scenario-label">Clinical Judgment</span><br>Apply NCJMM: Recognize cues (<span class="merci-kw">aPTT 110 vs target 60–80 + active bleeding: hematuria, gum oozing, new bruise</span>) → Analyze cues (heparin overanticoagulation; clinically significant bleeding) → Generate solutions (STOP infusion + provider notification + bleeding precautions + prepare protamine) → Take action (stop, notify, implement precautions, prepare antidote) → Evaluate outcomes (aPTT trending down, bleeding controlled, no major hemorrhage).<br><br><span class="merci-scenario-label">Memory Tip</span><br><span class="merci-kw-mark">Heparin antidote = Protamine sulfate. Warfarin antidote = Vitamin K.</span> Do not mix them up. <span class="merci-kw">aPTT > 2.5 × control or >100 seconds + active bleeding</span> always means STOP now.<br><br><span class="merci-scenario-label">KR vs US</span><br>Korean wards may wait for the next rounds or apply a 25% rate-reduction standing order, but NCLEX requires <span class="merci-kw">immediate STOP + immediate notification</span> when a critical lab is paired with active bleeding. <span class="merci-kw">Choosing vitamin K as the heparin antidote is always wrong on NCLEX.</span>

Clinical scenario

<span class="merci-scenario-label">Clinical Practice Guide</span><br><span class="merci-kw">ACCP / Chest heparin guidelines</span>: the therapeutic aPTT target is typically 1.5–2.5 × control (institution-specific, often 60–80 seconds). Critically elevated aPTT (>2.5 × control or >100 seconds) plus any clinical bleeding mandates immediate cessation. Protamine sulfate dosing: 1 mg neutralizes ~100 units of heparin given in the prior 2–3 hours, with a maximum single dose of 50 mg. Rapid IV administration may cause hypotension or anaphylaxis, especially with fish allergy or prior protamine exposure.<br><br><span class="merci-scenario-label">Caution</span><br><span class="merci-kw">Heparin = Protamine; Warfarin = Vitamin K; tPA = Aminocaproic acid; LMWH = Protamine (partial).</span> Antidote pairing is a high-yield NCLEX trap — vitamin K is never the heparin reversal agent. <span class="merci-kw">Bleeding precautions</span>: soft toothbrush, electric razor, no IM injections, fall prevention, stool softeners (avoid Valsalva), gentle suctioning, careful nail care, and pressure dressings on venipuncture sites.

Key concepts

• Activated partial thromboplastin time (aPTT) — A laboratory test of the intrinsic coagulation pathway. The therapeutic target during heparin therapy is typically 1.5–2.5 × control (commonly 60–80 seconds). Values >100 seconds or >2.5 × control with clinical bleeding warrant immediate cessation and provider notification.
• Protamine sulfate — The reversal agent (antidote) for heparin overdose. Dose: 1 mg neutralizes ~100 units of heparin given in the prior 2–3 hours, with a maximum single dose of 50 mg. Given IV slowly because rapid administration can cause hypotension or anaphylaxis, especially in clients with fish allergy or prior protamine exposure.
• Bleeding precautions — Nursing interventions that minimize bleeding risk during anticoagulation: soft toothbrush, electric razor, no IM injections, fall prevention, stool softeners to avoid Valsalva strain, gentle suctioning, careful nail care, and pressure dressings on venipuncture sites.